Dr. Christina Drenberg Guttke |
||
Dr. Christina Drenberg Guttke |
||
Biography |
||
Dr. Drenberg is currently a Research Assistant Professor at The Ohio State University in the College of Pharmacy, Division of Pharmaceutics and Pharmaceutical Chemistry. She studied biomedical sciences at the University of South Florida in her hometown of Tampa, FL and proceeded to earn her Ph.D. from the College of Medicine in Medical Sciences. She is passionate about identifying new treatment strategies for orphan diseases, like pediatric acute myeloid leukemia. |
||
Research Interest |
||
Dr. Drenberg’s primary research goals are to integrate genomic and transcriptomic data that define specific subtypes of pediatric acute myeloid leukemia (AML) with cutting-edge high-throughput screening techniques in order to identify novel therapeutic strategies to evaluate in preclinical models, translate the findings to clinical trials, and ultimately improve long-term outcome of childhood AML. The current focus of her laboratory is on the validation of leads identified in a high-throughput drug screen, with an interest in compounds demonstrating broad activity across subtypes and compounds with subtype selectivity. Her research incorporates clinical pharmacology principles (pharmacokinetics, pharmacodynamics, drug metabolism, drug transport, drug-drug interactions) during all aspects of drug development. |
||
Certificate | ||